Search

Your search keyword '"Zirpoli, Gary R"' showing total 133 results

Search Constraints

Start Over You searched for: Author "Zirpoli, Gary R" Remove constraint Author: "Zirpoli, Gary R"
133 results on '"Zirpoli, Gary R"'

Search Results

4. Smoking, Sex, and Non–Small Cell Lung Cancer: Steroid Hormone Receptors in Tumor Tissue (S0424)

7. Initial validation of the Mass. General Neuropathy Exam Tool (MAGNET) for evaluation of distal small‐fiber neuropathy.

8. Adherence to Cancer Prevention Lifestyle Recommendations Before, During, and 2 Years After Treatment for High-risk Breast Cancer

13. Supplemental Tables S1-S4 from Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium

15. Supplementary Materials and Methods. Immunohistochemical staining and automated analysis methods from Performance of Three-Biomarker Immunohistochemistry for Intrinsic Breast Cancer Subtyping in the AMBER Consortium

16. Data from Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium

17. Supplemental Table 1 from Biology and Etiology of Young-Onset Breast Cancers among Premenopausal African American Women: Results from the AMBER Consortium

18. Supplementary Table S2. Agreement between IHC-based and intrinsic subtype, using dichotomous biomarker IHC status from Performance of Three-Biomarker Immunohistochemistry for Intrinsic Breast Cancer Subtyping in the AMBER Consortium

19. Supplementary Table S1. Core level agreement between automated and manual scoring of central tissue microarrays from Performance of Three-Biomarker Immunohistochemistry for Intrinsic Breast Cancer Subtyping in the AMBER Consortium

20. Supplementary Table S3. Agreement between three biomarker IHC-based and intrinsic subtypes: impact of adding tumor grade to distinguish between luminal A and luminal B cases. from Performance of Three-Biomarker Immunohistochemistry for Intrinsic Breast Cancer Subtyping in the AMBER Consortium

22. Abstract GS4-04: Population-based Estimates of contralateral Breast Cancer Risk among Carriers of Germline Pathogenic Variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2

24. Supplement Use and Chemotherapy-Induced Peripheral Neuropathy in a Cooperative Group Trial (S0221): The DELCaP Study

28. Supplement use during an intergroup clinical trial for breast cancer (S0221)

30. Additional file 1 of Neighborhood disadvantage and individual-level life stressors in relation to breast cancer incidence in US Black women

31. Additional file 1 of Racial differences in CD8+ T cell infiltration in breast tumors from Black and White women

32. Epidemiology of Basal-like and Luminal Breast Cancers among Black Women in the AMBER Consortium

35. Physical Activity Before, During, and After Chemotherapy for High-Risk Breast Cancer: Relationships With Survival

36. Dietary Supplement Use During Chemotherapy and Survival Outcomes of Patients With Breast Cancer Enrolled in a Cooperative Group Clinical Trial (SWOG S0221)

37. Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221)

38. Cruciferous vegetable intake is inversely associated with lung cancer risk among smokers: a case-control study

39. Physical Activity Before, During, and After Chemotherapy for High-Risk Breast Cancer: Relationships With Survival.

40. Racial differences in CD8+ T cell infiltration in breast tumors from Black and White women.

41. Frequency of breast cancer subtypes among African American women in the AMBER consortium

42. Smoking, Sex, and Non–Small Cell Lung Cancer: Steroid Hormone Receptors in Tumor Tissue (S0424)

43. Biology and Etiology of Young-Onset Breast Cancers among Premenopausal African American Women: Results from the AMBER Consortium

46. Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk:Evidence from the Ovarian Cancer Association Consortium

47. Single nucleotide variants in metastasis‐related genes are associated with breast cancer risk, by lymph node involvement and estrogen receptor status, in women with European and African ancestry

48. Abstract 3413: Supplement use and chemotherapy-induced peripheral neuropathy in breast cancer patients treated on SWOG study S0221

49. Intratumoral heterogeneity as a source of discordance in breast cancer biomarker classification

50. Performance of Three-Biomarker Immunohistochemistry for Intrinsic Breast Cancer Subtyping in the AMBER Consortium

Catalog

Books, media, physical & digital resources